Phase II Trial of Clofarabine and Daunorubicin as Induction Therapy for Acute Myeloid Leukemia Patients Greater Than or Equal to 60 Years of Age

Leukemia Research - United Kingdom
doi 10.1016/j.leukres.2013.07.036

Related search